|
1
|
Abstract
This meeting was dedicated to various autoimmune diseases and their mechanisms, diagnosis and therapies. The autoimmunity-promoting factors included genetic variations and environmental injuries. A broad array of cytokines, including the B-cell activating factor, and autoantibodies, including novel specificities, were discussed. Finally, new horizons in treatment, including tolerogenic peptides, intravenous immunoglobulin and B-cell-depleting agents, were presented.
Collapse
Affiliation(s)
- Pierre Youinou
- European University of Brittany & Brest University Medical School Hospital, Brest, France
| |
Collapse
|